Jim Tananbaum shocked many when he was named among the top 100 investors on the Midas List for the three years in a row. Many did not understand what he did to achieve such a rare achievement. Probably you are wondering who Jim is and what makes him such a great investor. In large part, Jim secured a position on the prestigious list due to several healthcare achievements, which include the development of the diabetes treatment through one of his investment companies, Intarcia Therapeutics.
Jim Tananbaum is the Founder, Chairman and the President of a reputable investment firm called Foresite Capital. The investment firm mostly bets on emerging healthcare companies by providing them with capital, resources, information, and networks necessary to succeed. Foresite Capital has over $1.1 billion in assets under management. To present, Foresite has invested in more than 20 companies. Inclusive is Juno Therapeutics, which went public in 2014 and became one of the largest biotech companies. As the Founder, Jim is responsible for the development of Foresite Capital’s investment strategy. He is also an investor in Puma Biotechnology, a company that focuses on food allergy immunotherapy treatment. As the lead investor, Jim helped Puma Biotechnology secure more that $80 million in 2015. For more info visit LinkedIn
According to the report of Patient Daily, Jim’s journey started after University when he founded GelTex Pharmaceuticals, which introduced two effective drugs that built its reputation. GelTex was later acquired in 1998 for $1.6 billion by Sanofi-Genzyme. Today, GelTex still generates more than 1 billion in annual revenue, and it is about years after its launch. After the sale of GelTex, Jim founded Innovia, which was formally called Theravance. Innovia has a market capitalization of approximately $3.2 billion. Jim has invested in other companies like Jazz Pharmaceuticals, Healtheon, and Amira Pharmaceuticals, which was acquired by NYSE: BMS. According to Jim, the idea of starting Foresite Capital was triggered by his vision of joining all aspects of his education and career. You can search him on Google
The exceptional investor graduated with a Bachelor of Science degree from Yale University. He also holds an M.D from Harvard, an M.S. from MIT, and an MBA from Harvard Business School.